Directors
Barry Muncaster, Executive Director
Barry Muncaster was appointed to the Board in January 2009. Mr Muncaster was co-founder of BioProgress Technology Limited and BioProgress PLC (the forerunners to BioProgress ). Since May 2003 he has been active as an Angel Investor in several high technology start-ups.
Stephen Lee, Technical Director
Stephen Lee joined the BioProgress Technology business in 2004 as Engineering Director with a specific remit to drive the NRobe technology to satisfactory handover to FMC. He spent over two years developing the pilot machine at Harro Hoefliger GmbH and FarmaSierra. He went to work on the WaferTab™ and Tabwrap™ technologies, and took responsibility for all the technologies in Cambridge in May 2007. He was appointed as Chairman of the BioProgress Operational Board and was appointed Director of the BioTecFilms LLC manufacturing plant in January 2008, where he managed the development of a number of pharmaceutical film products to FDA standards.
He has been an agent for change management, and in a previous position as Technical and Engineering Director at The Denby Pottery, his remit was move the business from the 19th century to the 21st, and drive “Best Practice” through the departments.
Previously he was Director at the precision engineers TH Dixon Co Ltd, and at Protector Technologies the safety and medical device company.
He started his career in bioengineering and was a research scientist at Howmedica, the orthopedic implant device subsidiary of Pfizer.
He is a Fellow of the Institute of Mechanical Engineers.
Keith Hemming, International Sales and Marketing Director
Keith Hemming joined BioProgress in March 2007 as Head of Dexo Division. Since March 2009 Keith has taken over the newly created position of International Sales and Marketing Director for BioProgress with responsibility for the Company's global sales and distribution agents for current marketed products, and the commercialization of BioProgress's technology product portfolio.
Keith has over thirty years of experience in the Pharmaceutical industry, holding senior marketing and general management positions with Warner Lambert, Squibb Pharma and Yamanouchi Pharma. He was also General Manager of UK Operations for Fujisawa Pharma. He was a member of the Fujisawa European Senior Management Team, and worked with Astellas Pharmaceuticals’ Global Licensee Division on European strategy and implementation.
Keith was a member of the Board of Management of the ABPI for 4 years, and a member of the UK Pharmaceutical Code of Practice Appeal Board.
He was also founder and first Chair of the UK Japanese Pharmaceutical Group associated to the JPMA, and Chair of the Industry Group for the National Service Framework for Renal Services.
Jayne Phillips ACA, Finance Director
Jayne joined BioProgress in November 2006 from Grant Thornton as European Financial Controller. At Grant Thornton Jayne managed a portfolio of diverse growing businesses predominantly in the technology sector. In April 2007 Jayne was promoted to the role of Deputy Finance Director with a particular focus on European operations and corporate transactions.
Since joining the Company Jayne has introduced a new management reporting system and completed a number of corporate and product transactions and used her commercial skills to develop the business in a number of other key areas.
